Xencor Inc — Director's Dealing 2018

Feb 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2018-02-16

Reporting Person: Foster Paul A (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-16	Common Stock	M	5000	$0.59	Acquired	7419	Direct
2018-02-16	Common Stock	S	5000	$25.01	Disposed	2419	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-16	Stock Option (right to buy)	$0.59	M	5000	Disposed	2022-09-25	Common Stock (5000)	Direct

Footnotes

F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.

F2: The stock option is fully vested.